SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Federal National Mortgage Association is a government-sponsored company, which engages in the provision of liquidity for purchases of homes and financing of multifamily rental housing and refinancing existing mortgages. It operates through the Single-Family and Multifamily segments. The Single-Family segment offers liquidity to the mortgage market and increases the availability and affordability of housing for single families. The Multifamily segment includes guaranty fees on mortgages and on multifamily mortgage loans. The company was founded in 1938 and is headquartered in Washington, DC.

Federal National Mortgage Association

FNMA is seeing high community engagement driven by anticipation surrounding a potential IPO and end of conservatorship, spurred by the President's recent commentary regarding a trillion-dollar valuation for the GSEs. Investors are actively debating the timing of a potential re-listing, with discussions centered on recent analyst upgrades, the actions of high-profile investors like Bill Ackman and Michael Burry, and speculation about the impact of incoming leadership on the GSE framework.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is trending as investors await the upcoming earnings report, with community discussion centered on potential revenue growth, DefenCath adoption, and the impact of the pending CMS policy update. Shareholders are actively debating management's recent guidance and the long-term potential for expansion into oncology and TPN markets.

Dave, Inc. is a digital banking service. Its products include a budgeting tool to help members manage their upcoming bills to avoid overspending, cash advances through its flagship ExtraCash product to help members avoid punitive overdraft fees, a Side Hustle product, where Dave helps connect members with supplemental work opportunities, and Dave Banking, a modern checking account experience with valuable tools for building long-term financial health. The company was founded by Jason Wilk, Paras Chitrakar, and John Wolanin in October 2015 and is headquartered in Los Angeles, CA.

Dave Inc - Ordinary Shares - Class A

Dave Inc

Dave Inc. is trending as investors weigh strong fundamental growth, highlighted by triple-digit net income expansion, against recent regulatory scrutiny and market volatility. The community remains focused on the company's AI-powered underwriting efficiency, its competitive positioning within the fintech sector, and the potential impact of ongoing share repurchase programs.

Photronics, Inc. engages in the provision of photomasks, which are quartz or glass plates containing microscopic images of electronic circuits for use in the fabrication of integrated circuits and flat-panel displays. The company was founded by Constantine S. Macricostas in 1969 and is headquartered in Brookfield, CT.

Photronics, Inc.

Photronics is trending as investors digest the impact of its recent earnings miss and soft guidance, which triggered a significant short-term pullback in the stock. While some in the community view the current price as a deep-value opportunity given the company's strong balance sheet and role as a key photomask supplier for AI-driven chip demand, others are wary of the stock's recent technical weakness and the broader volatility across the semiconductor sector.

The Goldman Sachs Group, Inc. engages in the provision of financial services. It operates through the following business segments: Global Banking and Markets, Asset and Wealth Management, and Platform Solutions. The Global Banking and Markets segment includes investment banking, global investments, and equity and debt investments. The Asset and Wealth Management segment relates to the direct-to-consumer banking business which includes lending, deposit-taking, and investing. The Platform Solutions segment includes consumer platforms such as partnerships offering credit cards and point-of-sale financing, and transaction banking. The company was founded by Marcus Goldman in 1869 and is headquartered in New York, NY.

Goldman Sachs Group, Inc.

Goldman Sachs is trending as institutional investors aggressively pile into the stock, fueled by record-setting IPO pipelines and a robust broader financial sector rally. Community sentiment remains bullish, with many traders closely monitoring for a sustained breakout above the 1,000 level as analysts highlight the firm's pivotal role in mega-cap deals like the anticipated SpaceX offering.

ASML Holding NV engages in the development, production, marketing, sales, upgrading and servicing of advanced semiconductor equipment systems. It includes lithography, metrology and inspection systems. The company was founded on April 1, 1984 and is headquartered in Veldhoven, the Netherlands.

ASML Holding NV - New York Shares

ASML Holding NV

ASML is trending due to heightened investor sensitivity regarding export controls and intense scrutiny over semiconductor supply chains, while the community remains divided between those capitalizing on the dip as a long-term 'bottleneck' play and those concerned by volatile sector-wide reactions to earnings reports.

SolarEdge Technologies, Inc. engages in the development of energy technology, which provides inverter solutions. The firm operates through the following segments: Solar and All Other. The Solar segment includes the design, development, manufacturing, and sales of an inverter solution designed to maximize power generation. The All Other segment includes the design, development, manufacturing and sales of UPS products, energy storage products, e-Mobility products, and automated machines. Its products and services include photovoltaic inverters, power optimizers, photovoltaic monitoring, software tools, and electric vehicle chargers. The company was founded by Guy Sella, Lior Handelsman, Yoav Galin, Meir Adest, and Amir Fishelov on August 7, 2006 and is headquartered in Herzliya, Israel.

Solaredge Technologies Inc

SolarEdge is seeing significant market interest as it shifts toward AI-driven data center power infrastructure and solid-state transformer technology, with investors reacting to earnings reports and broader solar sector volatility. The community remains heavily divided between those betting on a long-term turnaround fueled by new product cycles and those focused on bearish technical factors, including ongoing litigation settlements and concerns over the company's profitability and debt levels.

Core Scientific, Inc. engages in the business of operating a purpose-built facility for digital asset mining and provision of blockchain infrastructure, software solutions, and services. It operates under the Mining and Hosting segments. The Mining segment focuses on bitcoin mining for the company's own account. The Hosting segment includes blockchain infrastructure and third-party hosting business. The company was founded by Michael Jeffrey Levitt and Darin Feinstein on December 13, 2017 and is headquartered in Dover, DE.

Core Scientific Inc - Ordinary Shares - New

Core Scientific Inc

Core Scientific is trending as institutional interest builds around its pivot from Bitcoin mining to high-performance AI infrastructure, with investors closely watching the company's progress on its gigawatt-scale data center pipeline and hyperscaler contracts. Community sentiment remains focused on the company's valuation gap compared to its sector peers and the potential for upcoming contract announcements to drive a significant re-rating.

Newegg Commerce, Inc. is an e-commerce company. It offers direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home and gaming products. The firm also provides third-party logistics services globally. The company was founded on July 22, 2003 and is headquartered in City of Industry, CA.

Newegg Commerce Inc

Newegg Commerce (NEGG) is trending due to persistent retail interest in its low-float structure, fueling intense speculation about a potential short squeeze as traders monitor thin liquidity and accumulation patterns. Community discussions are highly polarized, blending aggressive skepticism over long-term performance with bullish sentiment regarding insider share accumulation and strategic business pivots.

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include Revuforj and Niktimvo. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in New York, NY.

Syndax Pharmaceuticals Inc

Syndax Pharmaceuticals is trending as the community eagerly anticipates pivotal data readouts at the upcoming ASH meeting, with investors closely watching potential synergy with Incyte for a possible buyout. The sentiment is bolstered by strong Revuforj performance and community belief that the company remains significantly undervalued compared to its oncology peers.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why Is SMMT Stock Tumbling Today?

Equity

Summit announced a common stock offering, with underwriters having a 30-day option to purchase up to an additional $75 million of shares.

CADL Stock Heads For Best Week In A Month – Here’s Why Retail Is Bullish

Candel Therapeutics Phase 3 prostate cancer trial showed a higher disease-free survival rate.

Gilead, Merck, Eli Lilly Lead $106B Biopharma Takeover Wave In 2026

Biopharma M&A has surged to $106 billion across 201 deals through early June 2026, putting the sector on track for its strongest full-year total since the 2019 pre-pandemic peak, CNBC reported.

VSTM Stock Climbs After-Hours As FDA Grants Fast Track To Lung Cancer Drug — Retail Eyes The Next Keytruda 

The Fast Track designation is designed to help promising medicines for serious diseases reach patients faster by allowing more frequent contact with regulators and potentially quicker review.


ARDX Edges Up After Hours On IBSRELA Momentum And Profitability ‘Right Around The Corner’

CFO said at a conference that profitability is “right around the corner,” though the company is waiting for more top-line certainty before formal guidance.


VKTX Eyes Worst Week Since November As Trial Data Looms — Wall Street Still Sees 200% Upside

Data readout from the maintenance dosing study of VK2735, the company’s investigational obesity candidate, is expected in the third quarter. 


CELC Stock Records Worst Day Ever After Late-Stage Breast Cancer Trial Results — What’s Driving The Selloff?

The company reported three deaths in the trial, though none were associated with its experimental drug gedatolisib.


TVTX Stock Slides 6% On Everest Deal, Erases Some Losses As Analyst Sees 49% Upside

The licensing deal, announced Tuesday with China’s Everest Medicines, gives Travere exclusive rights to develop and sell the drug civorebrutinib in the United States.


ONCY Stock Heads For Sixth Straight Session Of Gains – Lead Therapy Shines in Early Combination Treatment Study

Oncolytics Biotech said preclinical data showed its experimental immunotherapy produced stronger anti-tumor effects in combination therapy, supporting future studies in pancreatic and colorectal cancers.

Is State Street SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?

SPDR Series Trust - State Street SPDR S&P Biotech ETF

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Stocktwits

Stocktwits Polls

SPDR S&P Biotech ETF

The sector is showing strong signs of a bullish breakout, with multiple investors tracking technical patterns and increasing momentum to fresh highs.

Investors are analyzing how changes in ETF weightings and sector rotation from passive funds are impacting price discovery for specific mid-cap biotech stocks.

Current Price	$140.72
Prev Close	$139.39
Open	$142.00
Dividend Yield	N/A
50-Day Moving Average	$133.39
Beta	N/A
Avg. Volume	8.25M
PE Ratio	N/A

52-Week High	$143.46
52-Week Low	$80.90
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

XBISPDR S&P Biotech ETF

Fundamentals

Feed

News

Sentiment

Fundamentals

Info

Latest XBI News